Cyclooxygenase regression model (with 95% CI) according to different prognostic variables
| Prognostic variable | P | Risk ratio (95% CI) | ||
|---|---|---|---|---|
| Risk of disease progression | ||||
| Autoimmunity | 0.0046* | 0.1646 (0.0472-0.5738) | ||
| Age | 0.1059 | 0.9764 (0.9485-1.0051) | ||
| Liver metastases | 0.3401 | 0.7044 (0.3429-1.4470) | ||
| Previous chemotherapy | 0.7919 | 0.8986 (0.4060-1.9886) | ||
| Performance status | 0.0877 | 1.2872 (0.9634-1.7200) | ||
| Sex | 0.6697 | 1.1621 (0.5827-2.3176) | ||
| Risk of death | ||||
| Autoimmunity | 0.0256* | 0.0884 (0.0105-0.7440) | ||
| Age | 0.6415 | 0.9916 (0.9570-1.0274) | ||
| Liver metastases | 0.8232 | 0.8970 (0.3457-2.3275) | ||
| Previous chemotherapy | 0.7046 | 0.8201 (0.2941-2.2867) | ||
| Performance status | 0.0042* | 1.7248 (1.1881-2.5040) | ||
| Sex | 0.7519 | 0.8776 (0.3905-1.9721) | ||
NOTE: Autoimmunity and performance status were the most predictive variables of prolonged TTP and survival.
↵* Statistically significant values.